Senior Associate Scientist, In Vitro / In Vivo CAR T Cells – South San Francisco, CA 94080

About Allogene:

Allogene Therapeutics, with headquarters in South San Francisco, is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) products for cancer and autoimmune disease. Led by a management team with significant experience in cell therapy, Allogene is developing a…
Click here to view original post